GOP Leaders Oppose Marijuana Reform as Rescheduling Moves
Photo by CRYSTALWEED cannabis via Unsplash.
The Trump administration is pushing ahead with a plan to reschedule cannabis. In the same stretch, congressional Republicans picked leaders with long track records of fighting marijuana reform.
The House and Senate GOP conferences elected their leaders on a Tuesday, reportedly November 10, as the party gets ready to move into the minority in the 120th Congress. That Congress is expected to start in early 2027.
What does that pairing mean for cannabis policy? Leadership opposition shapes legislation and messaging, but it does not control the executive rescheduling process.
Key takeaways
- Rep. Jim Jordan, newly elected House minority leader, has a long record of opposing marijuana reform, including 27 votes against proposals, per Marijuana Moment.
- Sen. John Thune joined a 2024 GOP letter attacking rescheduling and has opposed even modest cannabis banking proposals.
- Rescheduling is an executive-branch process, so hostile congressional leaders can criticize it but have less power to block it from the minority.
Who the New GOP Leaders Are

Photo by DEZALB via Pixabay.
According to Marijuana Moment, the House and Senate Republican conferences each elected leaders on a Tuesday, which appears to be November 10, 2026. The outlet's snippet doesn't state the date, so treat it as reported rather than confirmed. Exact titles should be checked against the conferences' own announcements.
On the House side, Rep. Jim Jordan of Ohio was elected by his GOP colleagues as minority leader. On the Senate side, Sen. John Thune is described as the top Republican senator. Given that the party is preparing for minority status, his title is likely minority leader, but that detail needs verification.
The minority framing comes from the coming 120th Congress, which begins in January 2027. Republicans are not taking the gavel; they are organizing for a different role.
What ties the two men together, per Marijuana Moment, is that both have long histories of strongly opposing marijuana reform. That is happening while the Trump administration advances its plan to federally reschedule cannabis. The leadership and the White House are not pulling in the same direction.
Jordan's Record on Cannabis
Jordan has been about as direct as a lawmaker can be. The article quotes him writing: As the ranking Republican member of the House Judiciary Committee, I fully support efforts to keep marijuana illegal. The snippet doesn't show when or where he wrote it, so the date and venue remain unverified.
The quote isn't an outlier. Marijuana Moment compiled a list of 27 times Jordan voted against marijuana reform proposals in Congress. That tally is the outlet's own count, and I haven't independently checked it, so attribute it accordingly.
Still, the shape of it is the point. Twenty-seven votes is a pattern, not one bad day or one stray amendment.
His Judiciary background is the piece to watch. Cannabis legislation, from descheduling bills to criminal justice provisions, often routes through that committee. A member who has put his support for keeping marijuana illegal in writing, and who has led the Republican side there, knows exactly where those bills can be slowed down.
Thune's History With Rescheduling and Banking
Thune's record is more layered. In 2024, he joined other Republican senators in a letter pressing the Biden administration to trash its rescheduling proposal. The letter also questioned whether marijuana has any medical value.
Here's the irony, stated plainly: the Trump administration has now advanced essentially that same policy. Senators who objected when a Democratic White House proposed it are watching a Republican one carry it forward.
Thune hasn't always sounded dismissive. In 2021, as Senate Democrats moved a legalization bill, he said cannabis reform is something we'll probably have to grapple with here. That's an acknowledgment of political reality, not an endorsement.
On the legislative side, Marijuana Moment says he has consistently opposed even modest proposals to allow marijuana industry banking. That's notable, since banking access is usually the easiest ask in the cannabis reform column.
Earlier pushback on Trump's plan is worth a brief note. The Hill reported GOP senators balking at it in late 2025, and Fox News reported House Republicans demanding he reverse course. Both are older reports, and I haven't reviewed their full text, so don't read them as current positions.
What Leadership Opposition Changes and What It Doesn't
Start with what leadership opposition doesn't touch. Rescheduling runs through the executive branch, meaning DEA rulemaking under the Controlled Substances Act, not a congressional floor vote. Before saying anything specific about where it stands, check the docket on federalregister.gov, regulations.gov and dea.gov. I couldn't confirm the current stage.
Minority status also trims the GOP's power. Without the majority, they don't set the floor agenda. But leaders can still shape messaging, push oversight, and fight over appropriations.
Where they do carry weight is legislation. Banking access or full descheduling still depends on committee and floor dynamics, and a leader's views influence what gets support and what gets quietly stalled.
And rescheduling is not legalization. It would not authorize adult-use sales. State law still governs what is legal where you live, so confirm your own state's rules rather than assuming federal movement changes them.
One tension to watch: Newsweek ran a headline reading Marijuana Industry Money Is Boosting Republicans Who Oppose Legalization. I reviewed only the headline, not the story. If the money is flowing to the same lawmakers who oppose reform, that gap will eventually get noticed.
The real story is a split. An administration is moving on cannabis, while a congressional GOP leadership that has not changed its position is about to lead a minority conference. The gap between them is where to look next. Watch for appropriations riders and oversight hearings, the tools a minority can still use.
For readers, the practical advice is to track the official rescheduling docket and your own state regulators rather than leadership rhetoric. The executive process is what actually changes federal status, and state rules are what govern your local market.
Sources
- Marijuana Industry Money Is Boosting Republicans Who Oppose Legalization - Newsweek
- Newly Elected Senate And House GOP Leaders Oppose Marijuana Reform As Trump Moves Ahead With Rescheduling - Marijuana Moment
- GOP senators balk at Trump’s plan to relax marijuana rules, warn it will hurt economy
- House Republicans demand Trump reverse course after 'strongly considering' marijuana executive order
- Trump’s Cannabis Rescheduling GOP Revolt & CRS Report Reality
- The Feds Want To Control Your Cannabis. Rescheduling Is Just the Opening Move.



